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Purpose:The mechanism of axial elongation in the myopic eyeball remains to be elucidated. It is known that the expression
profile for some proteins in the aqueous humor (AH) changes in some diseases. Accordingly, determinations of these AH
proteins may serve to understand their potential role in this pathogenesis. To identify the possible mechanism in myopia
development, a proteomic analysis of the AH composition from high myopic eyes (patients) was performed and compared
with that of the AH composition from non-myopic cataract eyes (controls).
Methods: Total protein concentration in AH was determined by the Bradford method, and separation profiles were
analyzed by two-dimensional (2D) gel electrophoresis. Protein in gel was determined by silver stain, and the separation
profiles were analyzed to assess spot density changes between myopia and non-myopia patients. These spots in gel were
isolated and identified by mass spectrometry.
Results: The total protein concentration in AH with high myopia was significantly greater than that of non-myopia. A
total of six spots were significantly increased in 2D gels from high myopia. The spots were derived from albumin,
transthyretin, and a vitamin D-binding protein.
Conclusions:The protein composition in AH was significantly different between myopia and non-myopia. The identified
proteins could be a potential biomarker for high myopia development and may play a role in the mechanisms of myopia
ocular axial elongation.
Myopia is the most common eye disease in the world with
substantial social, educational, and economic impact [1]. The
prevalence of high myopia (usually defined as eyes with ≥6
diopters  [D]  of  myopia  or  ≥26  mm  in  length)  in  world
populations has been estimated to be between 0.3% and 9.6%.
However, this percentage has recently been shown to be as
high as 16% in certain young Asian populations, and evidence
suggests  that  this  prevalence  is  increasing  [2].  It  is  well
documented that individuals with high myopia have a greatly
increased risk of ocular pathology such as retinal detachment,
macular  degeneration,  and  glaucoma  [3,4].  However,  the
pathogenesis of high myopia is not well understood. Previous
studies have focused upon investigating changes in the sclera,
retina, and choroid in high myopia, but few studies have been
directed toward assessing the aqueous humor (AH) in these
patients. It was reported that the pigment epithelium–derived
factor (PEDF) is elevated in patients with high myopia [5].
Such findings suggest that some proteins in AH might be
involved in the development of high myopia.
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AH is an important intraocular fluid responsible for the
supply of nutrients to and removal of metabolic wastes from
the  avascular  tissues  of  the  eye  [6].  It  contains  proteins
secreted from anterior segment tissues, and these proteins
could play a role in the pathogenesis of various eye diseases
[7]. It is known that protein levels in AH are changed in
various  eye  diseases.  Not  only  are  such  changes  in  AH
proteins observed in anterior segment disorders but also in
posterior  segment  disorders  [5,8-11].  In  addition,  an
increasing number of studies have demonstrated that some
proteins that changed in AH correlate with the mechanisms or
prognosis of many eye disorders [12-14].
In this report, we used proteomics as a means to identify
disease-specific  proteins  in  AH.  Through  comparative
analyses  of  the  proteomes  in  cataract  (control)  and  high
myopia  (patients),  it  is  possible  to  achieve  a  better
understanding of the molecular events involved in myopia
development  and  generate  essential  data  needed  for
elaborating  more  effective  strategies  with  regard  to
identification  of  new  biomarkers  and/or  treatments.  The
proteomic techniques used include protein separation by two-
dimensional gel electrophoresis (2-DE) and characterization
by mass spectrometry of peptides, amino acid sequencing, and
bioinformatics  analysis.  High  resolution  two-dimensional
(2D)  polyacrylamide  gel  electrophoresis  (PAGE)  is  a
technique for analyzing several hundred proteins in tissues,
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370fluids, or cells using only a few microliters of sample and is
therefore theoretically ideal for analyzing limited volumes of
AH. Funding et al. [15] have used the method to find the
different proteins in AH from patients with acute corneal
rejection. Accordingly, this platform has been widely used to
unravel and identify critical changes in myopia-related
proteins.
In this study, we investigated the differential proteomes
in five high myopias (patients) and matched cataracts
(controls). Abnormal expressions and distributions of proteins
from AH were identified and evaluated in age-paired clinical
specimens.
METHODS
Sample collection: AH samples were collected at Beijing
Tongren Eye Center, Capital Medical University, Beijing,
China. Informed consent was obtained from all patients.
During the period from October 2005 to May 2006, AH
samples were collected from five patients with high myopia
(patients) and from five age-matched cataract patients without
high myopia (controls). Patients with axial length ≥26 mm
were included as high myopia [16]. Axial lengths were
measured by ophthalmology ultrasonic diagnosis apparatus
(Quantel Medical, Echography, AXIS-II; Clermont-Ferrand,
Auvergne region, France). The control cases were determined
as having normal intraocular pressure (IOP; of less than
20 mmHg in at least two measurements separated by more
than one day) and were undergoing routine senile cataract
surgery for visual rehabilitation.
Case exemptions included patients with other ophthalmic
diseases (for example, glaucoma, uveitis, progressive retinal
disease), systemic diseases (for example, diabetes mellitus,
arthritis), and patients who received local medications or had
undergone previous laser or intraocular surgery.
All AH samples were obtained before ocular incision
during phacoemulsification surgery. Approximately 100-200
μl AH was collected by a 26 gauge ophthalmic cannula under
a binocular microscope. The AH was immediately stored in
aliquots of 50 μl in 1.5 ml microtubes at −80 °C until further
analysis.
Total protein quantization: Total AH protein concentration
was determined according to the Bradford method (Bio-Rad
Laboratories, Hercules CA) following the manufacturer’s
protocol. Bovine serum albumin (BSA) was used to create a
standard reference. AH (2 μl) from each sample was added to
18 μl distilled water and mixed with 200 μl of dye from the
Bradford reagent. After being incubated for 5 min at room
temperature, absorbances at 595 nm optic light were detected
by the fluorophotometer (DU800; Beckman Coulter, Inc,
Fullerton, CA). The protein concentration from each sample
was calculated according to the linearized BSA absorbance
curve.
Two-dimensional gel electrophoresis: The principle
procedure for running 2D gels has been described in detail
previously [15]. The AH samples (45 μl) were solubilized
directly in 55 μl lysis solution (8.0 M urea, 4% 3,3-
cholamidopropyl-dimethylammonio-1-propanesulfonate
[CHAPS], 0.5% IPG-buffer, pH 3–10) and 100 μl rehydration
solution (8.0 M urea, 2% CHAPS, 1% IPG-buffer, and 0.1 M
DTT) to achieve a total volume of 200 μl AH, lysis solution,
and rehydration solution. The final solution was used to
rehydrate immobilized pH gradient stripes overnight with
linear pH 3–10 at a length of 110 mm (Immobilize Drystripes;
Amersham Biosciences Inc., Amersham, UK).
For the first dimension, isoelectric focusing was
performed on an Ettan Multiphor II flat bed unit with minor
modifications of the manufacturer’s description (Amersham
Biosciences Inc., Amersham, UK). For the second dimension,
samples were separated by PAGE on a separating gel (1 mm
thickness, 12% SDS gel; Hoefer SE600 Ruby; Amersham
Biosciences Inc., Amersham, UK). The first-dimension gel
stripes and the molecular mass marker protein weight with a
range of 14.4-97.4 kDa were attached to the gel using 1%
agarose. A 20 mA constant current was applied per gel to run
the gel until the dye reached the approximate bottom of the
gel.
The separated proteins within the gels were fixed over a
2 h period in a 40% ethanol and 10% acetic acid solution
followed by the silver stain of protein in gel according to the
manufacturer’s protocol (Silver Stain Plus kit; BioRad).
Analysis of two-dimensional gels: The stained gels were
scanned with an Imagescanner (Amersham Biosciences Inc.)
and analyzed with Imagemaster 2D platinum software
(Amersham Biosciences Inc.). The gels were matched
according to the number of user-defined landmarks on the
gels. Each spot was quantified by using the volume and %
volume of the stained spot. We chose to work only the spots
with ratios that were greater than 2 between % volume in
patients and in controls.
Protein Identification by HPLC ESI-MS/MS: Gel pieces were
washed twice in 25 mM ammonium bicarbonate (AmBic) and
dried in a SpeedVac for 10 min. Samples were reduced in
10 mM dithiothreitol and 25 mM AmBic for 45 min at 50 °C
and then alkylated in 50 mM iodoacetic acid and 25 mM
AmBic for 1 h at room temperature in the dark. Gel pieces
were then washed twice in 25 mM AmBic and 50%
acetonitrile and vacuum-dried. Proteins were proteolysed
with 20 ng of modified trypsin (Promega, Madison, WI) in
25 mM AmBic overnight at 37 °C. The supernatant was
collected and peptides were further extracted in 0.1% acetic
acid and 60% acetonitrile. Peptide extracts were vacuum-
dried and resuspended in 20 μl of water for mass analysis.
Liquid chromatography/mass spectrometry/mass
spectrometry (LC MS/MS) analysis was performed in an LTQ
tandem mass spectrometer (ThermoFinnigan, San Jose, CA)
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371coupled online with an HPLC system. Protein digests obtained
above were loaded on the HPLC, which was connected with
an  in-house  made  fused  silica  capillary  column  (10-cm-
length; 100 µm inner diameter) and packed with sunchrom 5
μm C18 resin. High voltage (2.55 kV) was applied to the
HPLC  side  of  the  column  through  a  zero  dead  volume
MicroCross  PEEK  connector  (Upchurch  Scientific,  Oak
Harbor, WA). The peptides were sequentially eluted from the
HPLC  column  with  a  gradient  of  0-90%  of  Buffer  B
(acetonitrile:water:acetic  acid,  80:9.9:0.1)  in  Buffer  A
(acetonitrile:water:acetic acid, 5:94.9:0.1) at a flow rate of
approximately 500 nl/min using Voyager pumps. The eluted
peptides were sprayed directly from the tip of the capillary
column to the LTQ mass spectrometer for mass spectrometry
analysis. The LTQ was operated in a data-dependent mode
where the machine measured intensity of all peptide ions in
the mass range of 400 to 2000 (mass-to-charge ratios) and
isolated  the  peptide  peak  with  the  highest  intensity  for
collision-induced  dissociation.  All  tandem  spectra  were
searched  against  the  H.  sapiens  NCBI  reference  database
(human.nci)  using  SEQUEST  (version  2.7).  Results  were
filtered  by  Xcorr  +1>1.9,+2>2.5,+3>3.75,  sp>500,
Deltcn>0.1, Rsp<=5. Every protein identified matched at least
two peptides.
Statistics: SPSS Version 11.0 software was used to calculate
p-values as achieved with the Mann–Whitney test for all data
obtained.  A  p<0.05  was  required  for  the  results  to  be
considered statistically significant.
RESULTS
Ten  AH  samples  were  included  in  this  study,  five  from
cataract patients with high myopia (mean age 60±17.07 years;
three males and two females) and five from age-matched
cataract patients without myopia (mean age 64.4±15.65 years;
three  males  and  two  females).  There  was  no  statistically
significant difference between the two groups with regard to
age  (p=0.675).  Clinical  data  from  the  10  patients  are
summarized in Table 1.
Protein  content  in  aqueous  humor  from  patients  and
controls: The mean total protein level in AH from patients
with high myopia was 0.6956 mg/ml (range=0.3316-1.0516
mg/ml)  while  that  from  controls  was  0.3329  mg/ml
(range=0.2925-0.3397 mg/ml; Table 2). Total protein levels
in patients were significantly greater than that of controls
(p=0.009).
Two-dimensional  gel  electrophoresis  patterns:  Figure
1A,B show a representative gel from a patient (patient number
4 in Table 2) and a gel from a control subject (control number
4 in Table 2). Gels from patients displayed more spots and
more intensely silver stained spots than in gels from controls
(Figure 1B). There were significant differences in relative spot
volumes (% volume) in the gel patterns where patients showed
greater volumes than controls (Table 3). No protein spots were
TABLE 2. MEASUREMENT OF TOTAL PROTEIN IN THE AQUEOUS HUMOR OF PATIENTS
AND CONTROLS.
















The mean total protein level in AH from patients with high
myopia was 0.6956 mg/ml (Range = 0.3316~1.0516 mg/ml)
while  that  from  controls  was  0.3329  mg/ml  (Range  =
0.2925~0.3397 mg/ml).
TABLE 1. DATA FROM PATIENTS WITH MYOPIA AND FROM CONTROLS WITHOUT MYOPIA.
Group Number Age Sex VA Axial length (mm)Cataract
Patient 1 68 F CF 30.92 III-IV
2 49 M 39680 34.75 III
3 53 F 39498 31.7 III
4 86 M 39498 26.49 IV
5 44 M 39527 35.3 II-III
Control 1 73 F 39498 22.79 III-IV
2 68 M CF 22.31 III
3 55 F 39558 22.06 III
4 83 M 39558 23.02 IV
5 43 M 39527 23.38 II-III
Ten AH samples were included in this study, five from cataract patients with high myopia and five from age-matched cataract
patients without myopia. CF=Count Finger; VA=Visual Acuity.
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372found  to  be  downregulated  in  patients  compared  to  the
controls.
Identification of proteins: Based on the above results, six
protein spots were isolated for further analysis. Each spot was
acquired from the gel and digested extensively with trypsin.
The  resulting  peptides  were  applied  to  a  LC  MS/MS  for
measurements.  For  spot  1  (shown  to  have  a  significant
increase in patients), 10 peptides were captured and measured.
Figure 2 shows a typical MS/MS spectrum of its parent ion
m/z=1047.63(sequence:  SLGECCDVEDSTTCFNAK).
Many “y” and “b” series ions from this peptide were clearly
identified in this spectrum. Sequence searching indicated that
this peptide was from human vitamin D-binding protein. The
remaining nine peptides identified from protein spot 1 were
also located in vitamin D-binding protein. The total sequence
coverage was 32.70%.
Using the same methods, protein spot 2, with a significant
increase  in  patients,  was  identified  as  transthyretin  with
sequence coverage of 65.31%. Significantly increased protein
spots  3,  4,  5,  and  6  were  all  identified  as  albumins  with
sequence coverages of 29.72%, 18.90%, 5.25%, and 13.30%
respectively. When compared with the 2DE results, protein
spots 3 and 4 had similar molecular weights but different pI
values, suggesting that the difference between spots 3 and 4
may  be  caused  by  the  posttranslational  modification  of
albumin such as phospholation. Protein spots 5 and 6 had
lower molecular weights (spot 5=40.0 Da and spot 6=33.5 Da)
with a higher pI value than spot 3 and 4, indicating that protein
spots 5 and 6 were the hydrolyzed peptides of albumin at
different degrees. However, in the present study, the enzymes,
which result in the posttranslation modifications and albumin
degradation, remained undetected.
DISCUSSION
It has been demonstrated that various tissues of the eye are
involved  in  the  pathogenesis  of  high  myopia,  which  is
associated  with  active  scleral  elongation  and  tissue
remodeling.  The  choroidal  and  scleral  layers  of  the  eye
comprise the two principal targets of growth regulation. The
choroid  thickens  in  response  to  myopia  defocus  [17],  the
lymphatic vessels demarcate the scleral side of the choroids,
and the major choroidal blood vessels are constricted [18].
The development of high myopia is associated with reduced
scleral collagen accumulation, scleral thinning, and loss of
scleral  tissue  as  demonstrated  in  both  human  and  animal
models [19,20]. Numerous proteins are involved, including
structural components (such as collagen and proteoglycans
[21]),  enzymes  (such  as  the  matrix  metalloproteinases,
MMPs), and tissue inhibitors of metalloproteinases (TIMPs)
[22]. Evidence for local growth control necessarily implicated
the retina as the source of growth-modulating signals. Since
retinoic acid could play a role in the visual control of postnatal
eye growth in primates possibly by inducing changes in the
scleral extracellular matrix associated with increasing eye
size, the excessive enlargement of the eye seen in myopia is
known to be regulated, in part, by retinal neurotransmitters
[23]. The retinal pigment epithelial (RPE) may relay signals
between the retina and adjacent choroidal and scleral layers.
Three  retinal  neurotransmitters  (dopamine,  vasoactive
intestinal peptide, and glucagons that have been linked to eye
growth  regulation)  are  likely  to  affect  RPE  ion  and  fluid
transportation.  The  concentration  and  activity  of  growth
factors  acting  on  the  choroids  and  sclera  might  also  be
modulated by fluid transportation across the RPE [24].
Most of the recent insights regarding high myopia have
come from studies on animal models. In addition, these studies
typically focus on the retina, choroid, and sclera. In this study,
we directed our attention to proteins of the AH. AH can be
collected directly from patients, and the AH proteins might
manifest discrete changes in patients with high myopia. In
addition, it has been demonstrated that the total transforming
Figure  1.  Silver-stained  two-
dimensional gels of the aqueous humor.
AandB shows a representative gel from
a patient (patient number 4 in Table1)
and  from  a  control  subject  (control
number  4  in  Table1).  Total  protein
concentration in AH was 0.5577 mg/ml
from the patient and 0.2925 mg/ml from
the  control.  Arrows  and  numbers
showed  six  spots  with  volumes
significantly increased by values greater
than  twofold  in  the  patients.  The
identities of the spots were derived from
vitamin  D  binding  protein  (1),
tranthyretin (2), and albumin (3, 4, 5,
and 6).
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373TABLE 3. RESULTS FROM MASS SPECTROMETRY OF SIX DIFFERENT SPOTS IN THE AH OF MYOPIA PATIENTS.
Spot number Protein description Identified peptide MH+ Δ Cn Xcorr
1 Vitamin D-binding
protein precursor
K.LPDATPTELAK.L 1156.31 0.38 3.67
K.SLGECCDVEDSTTCFNAK.G 2094.24 0.36 2.72
K.AKLPDATPTELAK.L 1355.56 0.47 2.83
K.EVVSLTEACCAEGADPDCYDTR.T 2519.69 0.57 3.14
K.GQELCADYSENTFTEYK.K 2056.15 0.38 4.6
K.FPSGTFEQVSQLVK.E 1567.77 0.5 3.63
K.SYLSMVGSCCTSASPTVCFLK.E 2356.75 0.39 3.17
R.KFPSGTFEQVSQLVK.E 1695.94 0.36 4.56
K.EYANQFMWEYSTNYGQAPLSLLV SYTK.S 3205.54 0.36 4.13
K.VPTADLEDVLPLAEDITNILSK.C 2367.68 0.53 3.83
R.KAADDTWEPFASGK.T 1523.63 0.55 4.11
K.AADDTWEPFASGK.T 1395.46 0.46 3.65
R.GSPAINVAVHVFR.K 1367.58 0.37 2.59
2 transthyretin K.ALGISPFHEHAEVVFTANDSGPR.R 2452.67 0.42 5.41
K.TSESGELHGLTTEEEFVEGIYK.V 2456.6 0.56 4.27
R.RYTIAALLSPYSYSTTAVVTNPK.E 2517.86 0.62 4.68
R.YTIAALLSPYSYSTTAVVTNPKE. 2490.79 0.49 4.9
3 albumin precursor K.KVPQVSTPTLVEVSR.N 1640.91 0.53 5.23
K.FQNALLVR.Y 961.14 0.18 2.82
K.VPQVSTPTLVEVSR.N 1512.73 0.5 3.69
K.ADDKETCFAEEGKK.L 1628.71 0.49 4.9
K.LVAASQAALGL.- 1014.2 0.59 3.39
K.CCAAADPHECYAK.V 1553.63 0.36 4.29
R.RPCFSALEVDETYVPK.E 1912.12 0.32 3.87
K.QNCELFEQLGEYK.F 1658.78 0.56 4.37
K.EFNAETFTFHADICTLSEK.E 2261.42 0.62 5.65
K.AVMDDFAAFVEK.C 1343.53 0.5 3.94
K.AVM@DDFAAFVEK.C 1359.53 0.51 3.36
K.ADDKETCFAEEGK.K 1500.54 0.39 3.22
K.VFDEFKPLVEEPQNLIK.Q 2046.35 0.53 5.36
K.DVFLGM@FLYEYAR.R 1640.88 0.53 4.04
K.DVFLGMFLYEYAR.R 1624.88 0.46 4.25
R.MPCAEDYLSVVLNQLCVLHEK.T 2519.88 0.49 6.18
K.CCTESLVNR.R 1139.23 0.43 3.35
4 albumin precursor K.LVNEVTEFAK.T 1150.31 0.54 3.63
K.KVPQVSTPTLVEVSR.N 1640.91 0.52 3.65
K.VPQVSTPTLVEVSR.N 1512.73 0.52 3.72
K.QNCELFEQLGEYK.F 1658.78 0.6 4.29
K.YICENQDSISSK.L 1444.52 0.53 3.59
K.VFDEFKPLVEEPQNLIK.Q 2046.35 0.52 5.28
K.YICENQDSISSK.L 1444.52 0.51 3.8
K.SHCIAEVENDEMPADLPSLAADFV ESK.D 2976.21 0.46 5.73
K.ALVLIAFAQYLQQCPFEDHVK.L 2491.86 0.59 5.46
5 albumin precursor K.VFDEFKPLVEEPQNLIK.Q 2046.35 0.53 4.33
K.KVPQVSTPTLVEVSR.N 1640.91 0.54 2.83
6 albumin precursor K.FQNALLVR.Y 961.14 0.25 2.86
K.KVPQVSTPTLVEVSR.N 1640.91 0.54 4.28
K.VPQVSTPTLVEVSR.N 1512.73 0.46 3.14
R.RPCFSALEVDETYVPK.E 1912.12 0.26 3.64
K.AVM@DDFAAFVEK.C 1359.53 0.57 3.52
K.QNCELFEQLGEYK.F 1658.78 0.61 4.33
K.VFDEFKPLVEEPQNLIK.Q 2046.35 0.51 5.29
Results from mass spectrometry of six spots identified by two-dimensional gels to occur in the aqueous humor of patients with
myopia (n=5) in an amount at least twice that observed in controls (n=5). The spots were derived from vitamin D-binding
protein(No 1), transthyretin(No 2) and albumin(No 3-6).
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374growth factor (TGF) concentration of the AH shows slight
changes as associated with axial length [25]. However, few
studies have been involved with an examination of changes in
other AH proteins in myopia. Therefore, it was considered of
importance to study the changes of AH proteins that are
present in patients. Such information might offer new insights
to elucidate the mechanism of high myopia and identify
potential biomarkers of this condition.
In this study, we compared AH proteins between patients
with high myopia and non-myopic cataract (as the control).
The patterns of 2D electrophoresis gels in high myopia were
different from controls, which indicated that the protein
content in the AH changes with myopia development.
However, the origin and function of AH proteins is still
unknown. Results from previous studies have implicated that
AH proteins could activate signaling cascades, which
subsequently regulate cellular functions including mitosis,
differentiation, motility, and apoptosis. Such proteins play a
vital role in corneal wound healing, mediating the
proliferation of epithelial and stromal tissue, and affect
remodeling of the extracellular matrix (ECM). Moreover,
previous studies have demonstrated that AH could enter the
anterior choroidal fluid. When taken together, the findings
from these reports suggest that alterations in proteins could
contribute to the pathologic changes and complications of
myopia by at least two ways: by directly affecting the ocular
anterior segment or through effects upon choroidal tissues.
Further investigations are necessary to understand the exact
relationship between AH changes and high myopia.
Vitamin D-binding protein (DBP) is a multi-functional
plasma protein with many important functions. These include
transportation of vitamin D metabolites, control of bone
development, binding of fatty acids, sequestration of actin,
and a range of less well defined roles involved with
modulating immune and inflammatory responses [26].
However, the potential role of DBP functions in ocular tissues
remains unclear. To our knowledge, the present findings are
the first report indicating that DBP is related to high myopia.
Previous studies have demonstrated that Apolipoprotein A1
(ApoA1) and DBP are upregulated in certain diseases,
including procedures involved with transplantation of bone
marrow cells [27] and in hypercholesterolemia [28].
Moreover, it has been suggested that DBP might be involved
in the pathophysiology of the ApoA1 pathway in some
diseases. Such changes in ApoA1 and DBP can have
significant implications related to myopia. In a recent study,
Bertrand et al. [29] reported that ApoA1 was one of the
“STOP” signals for myopia. Hirai et al. [30] reported that
genetic variations of DBP were associated with insulin
resistance. Since elevated DBP would increase insulin
tolerance and decrease insulin-like growth factor-1 (IGF-1)
production [31] and it was demonstrated that IGF-1 could
increase myopia [32], a clear link between DBP and myopia
can be appreciated. Additionally, TGF-β is a transcriptional
regulator of 1,25D(3)-membrane-associated, rapid-response
steroid-binding (MARRS) expression via a functional Smad
3 element, and there exists cross-talk with the non-classical
1,25(OH)(2)D(3)-stimulated pathway [32]. As TGF-β
isoforms are involved in the control of scleral remodeling
during myopia development, the early alterations in TGF-β
expression levels may reflect a role for these cytokines in
mediating the retinoscleral signal that controls myopic eye
growth [33]. In our study, all cases were adults where axial
elongation should be stable. Therefore, we propose that DBP
might be involved in the STOP pathway of ApoA1 to balance
the possible “GROW” signals.
We also observed a significant increase of transthyretin
(TTR) in our patients. Since it has been reported that TTR
could be synthesized by ciliary pigment epithelium [34], this
suggests that the TTR upregulation in myopic AH might be
Figure 2. MS/MS spectrum of vitamin
D-binding protein derived peptide. The
vitamin D-binding protein peptide,
SLGECCDVEDSTTCFNAK ([M
+H]2+=1047.63), was identified using
this spectrum, which showed many
characteristic y and b series ions.
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375due to the alteration of ocular growth. Interestingly, TTR
exists in relatively high concentrations in body fluids like
serum and cerebrospinal fluid. Moreover, TTR has been
associated with diseases such as Alzheimer disease [35] and
type 2 diabetes [36]. Our current results suggest that TTR may
also be associated with myopia.
In our experiments, additional spots were identified,
which might be derived from albumin, according to the
characterization and previous reports [15]. However, the
albumin fragments obtained were different in pI and/or
molecular weights. While we do not have a complete
explanation for this finding, we speculate that it could be due
to the degradation of pathways of albumin in AH from these
patients.
In conclusion, the results of the present study revealed
that the proteomic composition of AH was significantly
different between the high myopia and control conditions. The
proteins identified could function as STOP signal candidates
and serve as potential biomarkers for myopia development.
ACKNOWLEDGMENTS
The study was supported by National Natural Science
Foundation grants (30471860 and 30400229) and Scientific
Research Common Program of Beijing Municipal
Commission of Education (KM200610025025).
REFERENCES
1. World Health Organization. Prevention of blindness and
deafness. Elimination of avoidable visual disability due to
refractive errors. (WHO/PBL200.79). 2000.
2. Lin LL, Shih YF, Tsai CB, Chen CJ, Lee LA. Hung Pt, Hou PK.
Epidemiologic study of ocular refraction among
schoolchildren in Taiwan. Optom Vis Sci 1999; 76:275-81.
[PMID: 10375241]
3. Scavello GS, Palura PC, Ganter WR, Young TL. Sequence
variants in the transforming growth β-induced factor (TGIF)
gene are not associated with high myopia. Invest Ophthalmol
Vis Sci 2004; 45:2091-7. [PMID: 15223781]
4. Grossniklaus HE, Green WR. Pathologic findings in pathologic
myopia. Retina 1992; 12:127-33. [PMID: 1439243]
5. Tong JP, Chan WM, Liu D, Lai TY, Choy KW, Pang CP, Lam
DS. Aqueous humor levels of vascular endothelial growth
factor and pigment epithelium–derived factor in polypoidal
choroidal vasculopathy and choroidal neovascularization.
Am J Ophthalmol 2006; 141:456-62. [PMID: 16490490]
6. To CH, Kong CW, Chan CY, Shahidullah M, Do CW. The
mechanism of aqueous humour formation. Clin Exp Optom
2002; 85:335-49. [PMID: 12452784]
7. Klenkler B, Sheardown H. Growth factor in the anterior
segment: role in tissue maintenance, wound healing and
ocular pathology. Exp Eye Res 2004; 79:677-88. [PMID:
15500826]
8. Janciauskiene S, Brandt L, Wallmark A, Westin U, Krakau T.
Secreted leukocyte protease inhibitor is present in aqueous
humours from cataracts and other eye pathologies. Exp Eye
Res 2006; 82:505-11. [PMID: 16202405]
9. Knepper PA, Mayanil CS, Goossens W, Wertz RD, Holgren C,
Ritch R, Allingham RR. Aqueous Humor in Primary Open-
Angle Glaucoma Contains an Increased Level of CD44S.
Invest Ophthalmol Vis Sci 2002; 43:133-9. [PMID:
11773023]
10. Ohguro H, Iaruyama M, Nakazawa M, Oohira A. Antirecoverin
Antibody in the Aqueous humor of a patient with cancer-
associated retinopathy. Am J Ophthalmol 2002; 134:605-7.
[PMID: 12383822]
11. Sakamoto T, Ito S, Yoshikawa H, Hata Y, Ishibashi T, Sueishi
K, Inomata H. Tissue factor increases in the aqueous humor
of proliferative diabetic retinopathy. Graefes Arch Clin Exp
Ophthalmol 2001; 239:865-71. [PMID: 11789868]
12. Määttä M, Tervahartiala T, Harju M, Airaksinen J, Autio-
Harmainen H, Sorsa T. Matrix metalloproteinases and their
tissue inhibitors in aqueous humor of patients with primary
open-angle glaucoma, exfoliation syndrome, and exfoliation
glaucoma. J Glaucoma 2005; 14:64-9. [PMID: 15650607]
13. Ozcan AA, Ozdemir N, Canataroglu A. The aqueous levels of
TGF-β2 in patients with glaucoma. Int Ophthalmol 2004;
25:19-22. [PMID: 15085971]
14. Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang IH,
Clark AF. TGFβ2-induced changes in human trabecular
meshwork: implications for intraocular pressure. Invest
Ophthalmol Vis Sci 2006; 47:226-34. [PMID: 16384967]
15. Funding M, Vorum H, Honoré B, Nexø E, Ehlers N. Proteomic
analysis of aqueous humour from patients with acute corneal
rejection. Acta Ophthalmol Scand 2005; 83:31-9. [PMID:
15715554]
16. Alio JL, Ruiz-Moreno JM, Shabayek MH, Lugo FL, Abd El
Rahman AM. The risk of retinal detachment in high myopia
after small incision coaxial phacoemulsification. Am J
Ophthalmol 2007; 144:93-8. [PMID: 17509510]
17. Wildsoet C, Wallman N. Choroidal and scleral mechanisms of
compensation for spectacle lenses in chicks. Vision Res 1995;
35:1175-94. [PMID: 7610579]
18. Liang H, Crewther S, Crewther D, Junghans B. Structural and
elemental evidence for edema in the retina, retinal pigment
epithelium, and choroids during recovery from
experimentally induced myopia. Invest Ophthalmol Vis Sci
2004; 45:2463-74. [PMID: 15277465]
19. Gentle A, Liu Y, Martin JE, Conti GL, McBrien NA. Collagen
Gene Expression and the altered accumulation of scleral
collagen during the development of high myopia. J Biochem
2003; 278:16587-94. [PMID: 12606541]
20. McBrien NA, Cornell LM, Gentle A. Structural and
ultrastructural changes to the sclera in a mammalian model of
high myopia. Invest Ophthalmol Vis Sci 2001; 42:2179-87.
[PMID: 11527928]
21. Hay ED. Extracellular matrix, cell skeletons, and embryonic
development. Am J Med Genet 1989; 34:14-29. [PMID:
2683777]
22. Siegwart, JT Jr; Norton, TT. Selective regulation of MMP and
TIMP mRNA levels in tree shrew sclera during minus lens
compensation and recovery. Invest Ophthalmol Vis Sci 2005;
46:3484-92. [PMID: 16186323]
23. Troilo D, Nickla DL, Mertz JR, Summers Rada JA. Change in
the synthesis rates of ocular retinoic acid and scleral
glycosaminoglycan during experimentally altered eye growth
Molecular Vision 2008; 14:370-377 <http://www.molvis.org/molvis/v14/a45> © 2008 Molecular Vision
376in marmosets. Invest Ophthalmol Vis Sci 2006; 47:1768-77.
[PMID: 16638980]
24. Rymer J, Wildsoet C. The role of the retinal pigment epithelium
in eye growth regulation and myopia: A review. Vis Neurosci
2005; 22:251-61. [PMID: 16079001]
25. Yamamoto N, Itonaga K, Marunouchi T, Majima K.
Concentration of transforming growth factor β2 in aqueous
humor. Ophthalmic Res 2005; 37:29-33. [PMID: 15637419]
26. Gomme PT, Bertolini J. Therapeutic potential of vitamin D-
binding protein. Trends Biotechnol 2004; 22:340-5. [PMID:
15245906]
27. Yokoyama Y, Terai S, Ishikawa T, Aoyama K, Urata Y,
Marumoto Y, Nishina H, Nakamura K, Okita K, Sakaida I.
Proteomic analysis of serum marker proteins in recipient mice
with liver cirrhosis after bone marrow cell transplantation.
Proteomics 2006; 6:2564-70. [PMID: 16548057]
28. Alonso-Orgaz S, Moreno L, Macaya C, Rico L, Mateos-Caceres
PJ, Sacristan D, Perez-Vizcaino F, Segura A, Tamargo J,
Lopez-Farre A. Proteomic study of plasma from moderate
hypercholesterolemic patients. J Proteome Res 2006;
5:2301-8. [PMID: 16944942]
29. Bertrand E, Fritsch C, Diether S, Lambrou G, Muller D,
Schaeffel F, Schindler P, Schmid KL, van Oostrum J, Voshol
H. Identification of apolipoprotein A-I as a "STOP" signal for
myopia. Mol Cell Proteomics 2006; 5:2158-66. [PMID:
16921168]
30. Hirai M, Suzuki S, Hinokio Y, Hirai A, Chiba M, Akai H,
Suzuki C, Toyota T. Variations in vitamin D-binding protein
(group-specific component protein) are associated with
fasting plasma insulin levels in Japanese with normal glucose
tolerance. J Clin Endocrinol Metab 2000; 85:1951-3. [PMID:
10843180]
31. Cordain L, Eades MR, Eades MD. Hyperinsulinemic diseases
of civilization: more than just Syndrome X. Comp Biochem
Physiol A Mol Integr Physiol 2003; 136:95-112. [PMID:
14527633]
32. Rohe B, Safford SE, Nemere I, Farach-Carson MC. Regulation
of expression of 1,25D3-MARRS/ERp57/PDIA3 in rat IEC-6
cells by TGF beta and 1,25(OH)2D3. Steroids 2007;
72:144-50. [PMID: 17188725]
33. Jobling AI, Nguyen M, Gentle A, McBrien NA. Isoform-
specific changes in scleral transforming growth factor-beta
expression and the regulation of collagen synthesis during
myopia progression. J Biol Chem 2004; 279:18121-6.
[PMID: 14752095]
34. Kawaji T, Ando Y, Nakamura M, Yamamoto K, Ando E,
Takano A, Inomata Y, Hirata A, Tanihara H. Transthyretin
synthesis in rabbit ciliary pigment epithelium. Exp Eye Res
2005; 81:306-12. [PMID: 16129098]
35. Biroccio A, Del Boccio P, Panella M, Bernardini S, Di Ilio C,
Gambi D, Stanzione P, Sacchetta P, Bernardi G, Martorana
A, Federici G, Stefani A, Urbani A. Differential post-
translational modifications of transthyretin in Alzheimer's
disease: a study of the cerebral spinal fluid. Proteomics 2006;
6:2305-13. [PMID: 16552785]
36. Sundsten T, Eberhardson M, Goransson M, Bergsten P. The use
of proteomics in identifying differentially expressed serum
proteins in humans with type 2 diabetes. Proteome Sci 2006;
4:22. [PMID: 17163994]
Molecular Vision 2008; 14:370-377 <http://www.molvis.org/molvis/v14/a45> © 2008 Molecular Vision
The print version of this article was created on 3 March 2008. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
377